Literature DB >> 24072680

Loss of NHE3 alters gut microbiota composition and influences Bacteroides thetaiotaomicron growth.

Melinda A Engevik1, Eitaro Aihara, Marshall H Montrose, Gary E Shull, Daniel J Hassett, Roger T Worrell.   

Abstract

Changes in the intestinal microbiota have been linked to diabetes, obesity, inflammatory bowel disease, and Clostridium difficile (C. difficile)-associated disease. Despite this, it remains unclear how the intestinal environment, set by ion transport, affects luminal and mucosa-associated bacterial composition. Na(+)/H(+)-exchanger isoform 3 (NHE3), a target of C. difficile toxin B, plays an integral role in intestinal Na(+) absorption. Thus the NHE3-deficient mouse model was chosen to examine the effect of pH and ion composition on bacterial growth. We hypothesized that ion transport-induced change in the intestinal environment would lead to alteration of the microbiota. Region-specific changes in ion composition and pH correlated with region-specific alteration of luminal and mucosal-associated bacteria with general decreases in Firmicutes and increases in Bacteroidetes members. Bacteroides thetaiotaomicron (B. thetaiotaomicron) increased in NHE3(-/-) terminal ileum and was examined in vitro to determine whether altered Na(+) was sufficient to affect growth. Increased in vitro growth of B. thetaiotaomicron occurred in 43 mM Na(+) correlating with the NHE3(-/-) mouse terminal ileum [Na(+)]. NHE3(-/-) terminal ileum displayed increased fut2 mRNA and fucosylation correlating with B. thetaiotaomicron growth. Inoculation of B. thetaiotaomicron in wild-type and NHE3(-/-) terminal ileum organoids displayed increased fut2 and fucosylation, indicating that B. thetaiotaomicron alone is sufficient for the increased fucosylation seen in vivo. These data demonstrate that loss of NHE3 alters the intestinal environment, leading to region-specific changes in bacteria, and shed light on the growth requirements of some gut microbiota members, which is vital for creating better treatments of complex diseases with an altered gut microbiota.

Entities:  

Keywords:  Bacteroides thetaiotaomicron; Clostridium difficile; Na+/H+-exchanger isoform 3; fucosylation; ileum

Mesh:

Substances:

Year:  2013        PMID: 24072680      PMCID: PMC3840232          DOI: 10.1152/ajpgi.00184.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  91 in total

1.  Enterococcus hirae vacuolar ATPase is expressed in response to pH as well as sodium.

Authors:  M Ikegami; M Kawano; K Takase; I Yamato; K Igarashi; Y Kakinuma
Journal:  FEBS Lett       Date:  1999-07-02       Impact factor: 4.124

2.  Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota.

Authors:  Vincent B Young; Thomas M Schmidt
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.

Authors:  M L Drumm; D J Wilkinson; L S Smit; R T Worrell; T V Strong; R A Frizzell; D C Dawson; F S Collins
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

4.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

5.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

Authors:  Maria Van der Sluis; Barbara A E De Koning; Adrianus C J M De Bruijn; Anna Velcich; Jules P P Meijerink; Johannes B Van Goudoever; Hans A Büller; Jan Dekker; Isabelle Van Seuningen; Ingrid B Renes; Alexandra W C Einerhand
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

6.  Glycan foraging in vivo by an intestine-adapted bacterial symbiont.

Authors:  Justin L Sonnenburg; Jian Xu; Douglas D Leip; Chien-Huan Chen; Benjamin P Westover; Jeremy Weatherford; Jeremy D Buhler; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

7.  A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem.

Authors:  L V Hooper; J Xu; P G Falk; T Midtvedt; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

8.  Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora.

Authors:  Stephan J Ott; Meike Musfeldt; Uwe Ullmann; Jochen Hampe; Stefan Schreiber
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

9.  Dietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk.

Authors:  Noortje IJssennagger; Muriel Derrien; Gerdien M van Doorn; Anneke Rijnierse; Bartholomeus van den Bogert; Michael Müller; Jan Dekker; Michiel Kleerebezem; Roelof van der Meer
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

10.  The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization.

Authors:  Rosana B R Ferreira; Navkiran Gill; Benjamin P Willing; L Caetano M Antunes; Shannon L Russell; Matthew A Croxen; B Brett Finlay
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

View more
  42 in total

Review 1.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

Review 2.  Trafficking Ion Transporters to the Apical Membrane of Polarized Intestinal Enterocytes.

Authors:  Amy Christine Engevik; James R Goldenring
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 10.005

Review 3.  Epithelial transport in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

Review 4.  Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.

Authors:  Melinda A Engevik; James Versalovic
Journal:  Microbiol Spectr       Date:  2017-10

5.  Organoids as a Model to Study Infectious Disease.

Authors:  Kristen A Engevik; Andrea L Matthis; Marshall H Montrose; Eitaro Aihara
Journal:  Methods Mol Biol       Date:  2018

6.  Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence.

Authors:  Melinda A Engevik; Lori D Banks; Kristen A Engevik; Alexandra L Chang-Graham; Jacob L Perry; Diane S Hutchinson; Nadim J Ajami; Joseph F Petrosino; Joseph M Hyser
Journal:  Gut Microbes       Date:  2020-05-13

7.  Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.

Authors:  Melinda A Engevik; Kristen A Engevik; Mary Beth Yacyshyn; Jiang Wang; Daniel J Hassett; Benjamin Darien; Bruce R Yacyshyn; Roger T Worrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-31       Impact factor: 4.052

8.  Helicobacter pylori-induced Sonic Hedgehog expression is regulated by NFκB pathway activation: the use of a novel in vitro model to study epithelial response to infection.

Authors:  Michael A Schumacher; Rui Feng; Eitaro Aihara; Amy C Engevik; Marshall H Montrose; Karen M Ottemann; Yana Zavros
Journal:  Helicobacter       Date:  2014-12-11       Impact factor: 5.753

9.  Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori.

Authors:  Sina Bartfeld; Hans Clevers
Journal:  J Vis Exp       Date:  2015-11-12       Impact factor: 1.355

10.  Alterations of Gut Microbiota After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Sprague-Dawley Rats.

Authors:  Yikai Shao; Rui Ding; Bo Xu; Rong Hua; Qiwei Shen; Kai He; Qiyuan Yao
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.